达格列净在老年及合并症患者中改善血糖且低血糖风险低。回顾性队列研究纳入2004-2019年英国CPRD GOLD数据库中8975例2型糖尿病 ...

Tight glycaemic control is essential for reducing the risk of long-term diabetic complications in people with type I or II diabetes. Intensive blood-glucose control attempts to normalise both pre- and ...

Learn the correct pronunciation of the Insulin Detemir, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, ...

SC- In insulin-native patients with type 2 diabetes who are not well controlled on oral antidiabetic drugs: Initial- 0.1-0.2 u/kg once daily in the evening or 10 u 1-2 times/day, adjust subsequently ...

In this Practice Point commentary, I describe the findings and limitations of a 52-week, open-label, noninferiority, head-to-head comparison study of the basal insulin analogs detemir and glargine.

Purpose: The pharmacology, pharmacokinetics, efficacy and tolerability, safety, drug interactions, dosage and administration, cost, and place in therapy of insulin detemir are reviewed. Summary: ...

Two long-acting insulin analogs have been developed for use as "basal" components of insulin treatment regimens: glargine and detemir. (Insulin glargine has US Food and Drug Administration [FDA] ...

Ethnicity & Disease, Vol. 27, No. 1, Cardiovascular Disease and Risk Factors (Winter 2017), pp. 45-54 (10 pages) Objective: To evaluate the effectiveness and safety of insulin detemir treatment as add ...

Please provide your email address to receive an email when new articles are posted on . A once-daily injection of detemir in a basal-bolus regimen was suitable as a routine starting schedule for ...

The primary job of basal insulin is to keep your blood glucose levels stable during periods of fasting, such as while you’re sleeping. Without this insulin, your glucose levels would rise at an ...

Sanofi announced the results of a real world outcome study on insulin glargine (Lantus) injection vs. insulin detemir (Levemir; Novo Nordisk) injection on A1C levels. The research was presented at the ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...